<?xml version="1.0" encoding="UTF-8"?>
<p id="p0225">Neurologically, SARS-CoV, and COVID-19 cases presented with seizures managed by propofol, phenytoin, and Levetiracetam. Valproate and midazolam also employed in addition to antibiotics hydroxychloroquine or antiviral 
 <xref rid="b0080" ref-type="bibr">[16]</xref>, 
 <xref rid="b0255" ref-type="bibr">[51]</xref>, 
 <xref rid="b0260" ref-type="bibr">[52]</xref>, 
 <xref rid="b0265" ref-type="bibr">[53]</xref>, 
 <xref rid="b0270" ref-type="bibr">[54]</xref>. Similarly, a five days intravenous immunoglobulin dosage have been employed among COVID-19 GBS patients, but no significant therapeutic benefit in improving GBS symptoms reported 
 <xref rid="b0350" ref-type="bibr">[70]</xref>, 
 <xref rid="b0355" ref-type="bibr">[71]</xref>.
</p>
